STOCK TITAN

Optimus Healthcare Svcs Stock Price, News & Analysis

OHCS OTC

Company Description

Optimus Healthcare Services, Inc. (OTC PINK:OHCS) is a forward-thinking healthcare company committed to advancing clinical research, disease management, and improving physician-patient interactions. Headquartered in New York, NY, Optimus is building a robust network of innovative healthcare entities that provide access to cutting-edge vaccines and pharmaceuticals.

Recently, Optimus announced a significant development in the healthcare industry. On August 16, 2023, the company entered into a Memorandum of Understanding (MoU) with RUA Diagnostics, Inc. This agreement sets the stage for a potential joint venture aimed at commercializing a groundbreaking diagnostic device based on a Patent License Agreement involving RUA and the Regents of the University of Michigan.

This innovative technology employs micro-gas chromatography and miniature gas detectors, bolstered by sophisticated software and artificial intelligence, to analyze breath samples for detecting various human and animal diseases. The initial focus will be on diagnosing conditions such as sepsis, ARDS (acute respiratory distress syndrome), pneumonia, traumatic brain injury, and other inflammatory diseases and cancers. Moreover, this technology allows for monitoring disease progression or improvement in patients.

This cutting-edge technology is the result of collaborative efforts between the University of Michigan's College of Engineering and the Weil Institute for Critical Care Research and Innovation. It was developed under the expert guidance of Dr. Xudong Fan, Professor of Biomedical Engineering, and Dr. Kevin Ward, Professor of Emergency Medicine.

The research has already demonstrated promising results in diagnosing COVID-19 and ARDS, thanks to funding from the Department of Defense and the National Institutes of Health. The joint efforts between RUA Diagnostics and Optimus Healthcare Services aim to further enhance this technology to revolutionize diagnostic capabilities in the healthcare sector.

As a company, Optimus remains committed to leveraging innovative technologies and partnerships to provide better health outcomes, thereby making a significant impact on global healthcare.

Stock Performance

$0.0725
0.00%
0.00
Last updated: April 27, 2025 at 12:06
- %
Performance 1 year
$4.0M
Market Cap
50.0M
Shares outstanding

SEC Filings

No SEC filings available for Optimus Healthcare Svcs.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Diluted EPS (TTM)
Operating Cash Flow
Net Profit Margin
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Optimus Healthcare Svcs (OHCS)?

The current stock price of Optimus Healthcare Svcs (OHCS) is $0.0725 as of April 25, 2025.

What is the market cap of Optimus Healthcare Svcs (OHCS)?

The market cap of Optimus Healthcare Svcs (OHCS) is approximately 4.0M.

What does Optimus Healthcare Services, Inc. do?

Optimus focuses on creating a network of innovative healthcare companies that advance clinical research, disease management, and improve physician-patient interactions.

What recent achievement has Optimus Healthcare Services announced?

Optimus recently entered a Memorandum of Understanding with RUA Diagnostics to commercialize a diagnostic device for various diseases.

What diseases will the new diagnostic device target?

The device targets diseases such as sepsis, ARDS, pneumonia, traumatic brain injury, and other inflammatory diseases and cancers.

Who are the key partners in the development of the new diagnostic technology?

The technology was developed in collaboration with the University of Michigan's College of Engineering and the Weil Institute for Critical Care Research and Innovation.

How does the new diagnostic technology work?

It uses micro-gas chromatography and miniature gas detectors along with AI-driven software to analyze breath samples for disease detection.

Has the technology been tested on any diseases?

Yes, it has demonstrated the ability to diagnose COVID-19 and ARDS.

Who funded the development of this technology?

The technology development was funded, in part, by the Department of Defense and the National Institutes of Health.

What is the purpose of the joint venture between Optimus and RUA Diagnostics?

The joint venture aims to commercialize the diagnostic device and enhance its use in detecting and monitoring various diseases.

Who are the notable figures involved in developing the diagnostic technology?

Notable figures include Dr. Xudong Fan, Professor of Biomedical Engineering, and Dr. Kevin Ward, Professor of Emergency Medicine.

Where is Optimus Healthcare Services, Inc. headquartered?

Optimus Healthcare Services, Inc. is headquartered in New York, NY.